lactobacillus gasseri (BGP345A)
/ BioGaia
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 04, 2025
Therapeutic Value of Lactobacillus gasseri 345A in Chronic Constipation.
(PubMed, Neurogastroenterol Motil)
- "Treatment with Lactobacillus gasseri can alleviate pain sensations in functional constipation, possibly with an improved bowel-emptying function."
Journal • Constipation • Gastroenterology • Gastrointestinal Disorder • Pain • TRPV1
February 14, 2023
OIC1: Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications
(clinicaltrials.gov)
- P2 | N=126 | Recruiting | Sponsor: BioGaia Pharma AB | Trial completion date: Jan 2023 ➔ Dec 2023 | Trial primary completion date: Jan 2023 ➔ Dec 2023
Trial completion date • Trial primary completion date • Constipation • Gastroenterology • Gastrointestinal Disorder • Oncology • Pain
November 24, 2021
OIC1: Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications
(clinicaltrials.gov)
- P2; N=126; Recruiting; Sponsor: BioGaia Pharma AB
Clinical • New P2 trial • Constipation • Gastroenterology • Gastrointestinal Disorder • Oncology • Pain
1 to 3
Of
3
Go to page
1